The approval of the drug’s recreational and medicinal consumption in dozens of states over the last decade has been accompanied by benefits like destigmatization and the growth of a multi-million-dollar industry, but problematic use and the continued incarceration of individuals on possession charges tarnish its successful narrative
“Next up: lobbyists are complaining that the prison-industrial complex is chronically missing projected earnings, to the tune of roughly 40 billion dollars.”